On Jan. 26, executive chairman John Burzynski bought 400,000 shares at a cost of 98.3 cents per share, increasing the ...
The Vancouver development remains paused, the company wrote in a press release on Wednesday. Its two other Voilà fulfilment ...
Sanofi’s investment and participating investors will drive the progression of the genetic medicine pipeline, notably SENS-601 (GJB2-GT). This funding supports key catalysts for the program which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results